Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6876 USD | -1.11% | +0.45% | -9.11% |
14/05 | Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
26/04 | Citius Pharmaceuticals Launches $15 Million Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.11% | 12Cr | |
+29.03% | 4.92TCr | |
-0.10% | 4.21TCr | |
+47.92% | 4.04TCr | |
-5.26% | 2.89TCr | |
+11.48% | 2.61TCr | |
-22.74% | 1.87TCr | |
+9.06% | 1.33TCr | |
+30.01% | 1.23TCr | |
-1.51% | 1.2TCr |
- Stock Market
- Equities
- CTXR Stock
- News Citius Pharmaceuticals, Inc.
- Citius Pharmaceuticals Resubmits Application for Lymphoma Treatment